We are live on ! Find out more
ELEV

Elevation Oncology
ELEV

Delisted

ELEV was delisted on the 22nd of July, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of ELEV yet.

ELEV Hedge Fund Activity: Q4 2025 in Review

0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Elevation Oncology (ELEV) for Q4 2025, worth a combined $0 — down 100% from $720 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ELEV and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Osaic Holdings, exiting entirely with an estimated $720 sold.

  • 0 institutional investors held Elevation Oncology (ELEV) as of Q4 2025, down from 1 in Q3 2025.
  • Funds reported $0 of Elevation Oncology stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Elevation Oncology positions in Q4 2025 and 1 closed out, a net change of -1 holder.
  • The largest Elevation Oncology seller in Q4 2025 was Osaic Holdings, an estimated $720 sold.

Based on aggregated 13F filings for Q4 2025.